<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

News and Stories

Recent Medical & Health Science News Stories | Multiple Sclerosis (MS)

Multiple Sclerosis (MS)

New Findings Indicate Metabolic Dysfunction as a Driver of Immune Cell Attack to Brain Cells in Multiple Sclerosis

Researchers at the University of Colorado Anschutz Medical Campus are part of an international team that has discovered a molecular signature that plays a pivotal role in sustaining the activation of immune cells in chronic neurological diseases, including progressive multiple sclerosis (MS).

Author Laura Kelley | Publish Date March 14, 2024
Full Story

Research    Patient Care    Multiple Sclerosis (MS)

At the Forefront: Driving Breakthroughs in Multiple Sclerosis

Multiple sclerosis, or MS, affects several million people worldwide, with Colorado claiming one of the highest rates in the country. About one in 360 people in our state has MS, and women with the disease outnumber men by about three to one. Most often diagnosed between the ages 20 to 40, MS generally strikes patients during the prime of life.

Author Staff | Publish Date March 11, 2024
Full Story

Clinical Research    Autoimmune disease    Multiple Sclerosis (MS)

Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis

University of Colorado Anschutz Medical Campus researchers are part of an international team that has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.

Author Laura Kelley | Publish Date November 27, 2023
Full Story

Research    Patient Care    Autoimmune disease    Multiple Sclerosis (MS)

Could a Blood Test Revolutionize Multiple Sclerosis Diagnosis?

A simple blood test into multiple sclerosis (MS) pathology could speed MS diagnostics and ultimately improve patient care, according to Xiaoli Yu, PhD, senior author of a new study on plasma immunoglobulin G (IgG) antibody aggregates.

Author Chris Casey | Publish Date November 09, 2023
Full Story